This study will assess a medicine called isoquercetin to see if it can prevent a venous thromboembolism (VTE) in patients getting treatment for pancreatic, colorectal, & non-small cell lung cancer. To participate in this study, you must be at least 18 years old & must not have been diagnosed with VTE in the last two years. The study has nine locations in California, Connecticut, Maine, Massachusetts, Missouri, Vermont, & Washington, D.C.
This study is testing a six-week course of blood-thinning medicines for the treatment of venous thromboembolisms (VTE) to see if they are as effective as the standard treatment course of three months. To participate in this study, you or your child must be younger than 21 years old. This study has 54 locations in Alabama, Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Texas, Utah, Virginia, Wisconsin, Australia, Austria, Canada, Israel, & the Netherlands.
This study is comparing two treatments for blockages in veins of the thigh or back: a medicine delivered directly to the blood clot via a tube & standard blood-thinning medicine. The researchers will compare how well both treatments work to resolve the deep vein thrombosis (DVT) in the short term & whether long-term outcomes differ at two years after the initial treatments. To participate in this study, you must be 6 to 21 years old. This study is located in Denver, Colorado.
This study will investigate physical activity habits among children recovering from a deep vein thrombosis (DVT) to see if a fitness tracker can help them maintain regular physical activity. The study will also assess the impact of exercise on their health & quality of life. To participate in this study, your child must be between 7 to 21 years old. The study is located in Dallas, Texas.
This study is exploring why some people experience complications after venous thromboembolism (VTE) treatment & why other people do not. Someday this may help doctors predict which children or young adults are likely to develop complications. To participate in this study, you must have been recently treated for VTE & be younger than 21 years old. This study is located in Dallas, Texas.